NCT01026389View on ClinicalTrials.gov

Efficacy Evaluation of Dotarem Compared to Gadovist in the Diagnosis of Peripheral Arterial Disease

PHASE4CompletedINTERVENTIONAL
Enrollment

189

Participants

Timeline

Start Date

October 31, 2009

Primary Completion Date

June 30, 2011

Study Completion Date

January 31, 2012

Conditions
Peripheral Arterial Disease
Interventions
DRUG

Dotarem

DOTAREM, 0.1 mmoL/kg (0.2 mL/kg), intravenous (I.V.) bolus

DRUG

Gadovist

Gadovist, 0.1mmol/kg (0.1mL/kg), intravenous (I.V.) bolus

Trial Locations (1)

Unknown

AKH hospital, Vienna

Sponsors

Lead Sponsor

Guerbet
All Listed Sponsors
lead

Guerbet

INDUSTRY